An observational study in Healthy, sponsored by Istanbul Medeniyet University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-30.
Sponsored by Istanbul Medeniyet University · Observational
The aim of this study is to determine the normative values of navicular height and navicular drop in individuals over 65 years of age. The secondary aim is to investigate the effects of age, gender, and body mass index on these normative values.
Istanbul Medeniyet University is the lead sponsor of 188 studies on the registry; 18 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Healthy older adults
Exclusion Criteria:
≥65-\<75 years of age
≥75-\<90 years of age
Navicular Drop Test
The navicular height and the amount of navicular drop will be made separately for each foot. The navicular prominence is found by palpation and marked with a marker pen when the individual is in a sitting position with the hips and knees flexed to 90 degrees and the subtalar joint in neutral position (the subtalar joint is palpated and the talus is in a neutral position). The height of the navicular protrusion from the ground is measured with a rigid ruler. Then, while the person stands on both feet equally, the height of the navicular protrusion from the ground is also measured with a ruler. The difference between the two measurements is noted as the amount of "navicular drop" (NDT).
Time frame: 10 minutes
Age
Age
Time frame: 1 minute
Gender
Gender
Time frame: 1 minute
Body-Mass index
weight/ (height)2
Time frame: 3 minutes
Foot Posture Index
FPI
Time frame: 15 minutes
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Istanbul Medeniyet University